Cargando…
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
The combination of chemotherapy and immunotherapy motivates a potent immune system by triggering immunogenic cell death (ICD), showing great potential in inhibiting tumor growth and improving the immunosuppressive tumor microenvironment (ITM). However, the therapeutic effectiveness has been restrict...
Autores principales: | Ma, Xianbin, Yang, Shaochen, Zhang, Tian, Wang, Shuo, Yang, Qichao, Xiao, Yao, Shi, Xiaoxiao, Xue, Peng, Kang, Yuejun, Liu, Gang, Sun, Zhi-Jun, Xu, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800001/ https://www.ncbi.nlm.nih.gov/pubmed/35127398 http://dx.doi.org/10.1016/j.apsb.2021.05.016 |
Ejemplares similares
-
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018) -
Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity
por: Yang, Qichao, et al.
Publicado: (2022) -
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
por: Xiao, Yao, et al.
Publicado: (2021) -
Bioresponsive nanotherapy for preventing dental caries by inhibiting multispecies cariogenic biofilms
por: Liu, Danfeng, et al.
Publicado: (2021) -
Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy
por: Liang, Yuanwei, et al.
Publicado: (2018)